Publication:
Implant exposure and extrusion

dc.contributor.authorChristina Garusien_US
dc.contributor.authorVisnu Lohsiriwaten_US
dc.contributor.otherIstituto Europeo di Oncologiaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:37:48Z
dc.date.available2018-10-19T05:37:48Z
dc.date.issued2013-01-01en_US
dc.description.abstract© Springer-Verlag Italia 2013. The salvage of the infected and or exposed breast prosthesis remains a challenging but viable option for a subset of patients. Keys to success include culture-directed antibiotics, capsulectomy, device exchange, and adequate soft tissue coverage. Relative contraindications to breast device salvage include atypical pathogens on wound culture, such as Gram-negative rods, methicillin-resistant <Emphasis Type=–Italic—>Staphylococcus aureus</Emphasis>, and <Emphasis Type=–Italic—>Candida parapsilosis</Emphasis>. Patients with a prior device infection and exposure and a history of either radiotherapy or <Emphasis Type=–Italic—>S. aureus</Emphasis> on wound culture should be closely monitored for signs of recurrent breast prosthesis infection/exposure and managed cautiously in the setting of elective breast surgery.en_US
dc.identifier.citationOncoplastic and Reconstructive Breast Surgery. (2013), 315-320en_US
dc.identifier.doi10.1007/978-88-470-2652-0_32en_US
dc.identifier.other2-s2.0-84956726027en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/32649
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84956726027&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleImplant exposure and extrusionen_US
dc.typeChapteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84956726027&origin=inwarden_US

Files

Collections